A nonproteolytic strain of Clostridium botulinum type B produces two toxins of different molecular weight (16S and 12S) that are indistinguishable from the corresponding toxins of a proteolytic strain in molecular weight and construction but differ in potential toxicity, activation ratio, and hemagglutinability. Successful hybridization between the toxic and nontoxic components (both 7S) of 12S toxins of biologically heterologous type B strains confirmed the physicochemical similarity between the toxic as well as the nontoxic components.All Clostridium botulinum type A and some type B and F strains are proteolytic; all type C, D, and E strains and some type B and F strains are nonproteolytic. Nonproteolytic strains of types B, E, and F are known to produce toxins that are activated upon trypsinization (2, 3, 5). The progenitor toxin of a proteolytic type B strain Okra was obtained in two different molecular forms, 16S (L toxin) and 12S (M toxin) (9). Both L and M toxins consist of neurotoxic and nontoxic components. The neurotoxic component of either toxin has a molecular weight of 170,000 (7S) (1,8). The nontoxic component of L toxin is about 12S and contains hemagglutinin activity, whereas that of M toxin is 7S and contains no hemagglutinin activity (9).The toxins of proteolytic and nonproteolytic type B strains are slightly different antigenically (11,12). The cultural and biological properties of nonproteolytic type B strains are more like those of type E and therefore different from those of proteolytic type B strains in that gas formation in carbohydrate fermentation is strong, the minimum growth temperature is 3 C, and the maximum heat resistance of spores is about 30 min at 60 C (13). The binding and competition of deoxyribonucleic acid isolated from cultures showed that a nonproteolytic type B strain was 100% homologous, whereas a proteolytic type B strain was only 11% homologous to a type E strain (10).The toxin of a nonproteolytic type B strain has never been purified. We attempted to purify the progenitor toxin(s) of a nonproteolytic type B strain QC and compared their molecular construction and other properties with those of a proteolytic type B strain Okra. Kitamura and Sakaguchi (6) succeeded in reconstructing type E 12S toxin molecules with the dissociated 7S toxic and 7S nontoxic components, but failed to achieve hybridization between components of type E and A progenitor toxins. We also attempted to make hybrids with each component of M toxin of the nonproteolytic strain and the matching components of the M toxin of a proteolytic strain of C. botulinum type B and succeeded in achieving hybridization in any combination.Nonproteolytic C. botulinum type B strain QC was grown in peptone-yeast extract-glucose medium for 4 days at 30 C. Progenitor toxins were purified by procedures similar to those used for purifying toxins of proteolytic type B strain Okra (9). Determinations of toxicity, protein, ribonucleic acid, and direct hemagglutinin, polyacrylamide gel electrophoresis, and agar gel diffusion w...